Follow
Jeremy S. Lum
Jeremy S. Lum
University of Wollongong/Illawarra Health and Medical Research Institute
Verified email at uow.edu.au
Title
Cited by
Cited by
Year
Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer’s disease
R Balez, N Steiner, M Engel, SS Muñoz, JS Lum, Y Wu, D Wang, ...
Scientific reports 6 (1), 31450, 2016
2452016
Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture
N Matosin, E Frank, M Engel, JS Lum, KA Newell
Disease models & mechanisms 7 (2), 171-173, 2014
2402014
Supplement of microbiota-accessible carbohydrates prevents neuroinflammation and cognitive decline by improving the gut microbiota-brain axis in diet-induced obese mice
H Shi, Q Wang, M Zheng, S Hao, JS Lum, X Chen, XF Huang, Y Yu, ...
Journal of neuroinflammation 17, 1-21, 2020
882020
Molecular evidence of synaptic pathology in the CA1 region in schizophrenia
N Matosin, F Fernandez-Enright, JS Lum, M Engel, JL Andrews, ...
npj Schizophrenia 2 (1), 1-8, 2016
782016
Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I: C) model relevant to …
AL Osborne, N Solowij, I Babic, JS Lum, KA Newell, XF Huang, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 95, 109666, 2019
472019
Cannabidiol improves behavioural and neurochemical deficits in adult female offspring of the maternal immune activation (poly I: C) model of neurodevelopmental disorders
AL Osborne, N Solowij, I Babic, JS Lum, XF Huang, KA Newell, ...
Brain, behavior, and immunity 81, 574-587, 2019
462019
Shifting towards a model of mGluR5 dysregulation in schizophrenia: consequences for future schizophrenia treatment
N Matosin, F Fernandez-Enright, JS Lum, KA Newell
Neuropharmacology 115, 73-91, 2017
462017
Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation
N Matosin, F Fernandez-Enright, SJ Fung, JS Lum, M Engel, JL Andrews, ...
Acta neuropathologica 130, 119-129, 2015
452015
Sex differences in the neurochemistry of frontal cortex: Impact of early life stress
CJ Perry, EJ Campbell, KD Drummond, JS Lum, JH Kim
Journal of Neurochemistry 157 (4), 963-981, 2021
362021
Amyotrophic lateral sclerosis: proteins, proteostasis, prions, and promises
L McAlary, YL Chew, JS Lum, NJ Geraghty, JJ Yerbury, NR Cashman
Frontiers in Cellular Neuroscience 14, 581907, 2020
352020
Perinatal exposure to fluoxetine increases anxiety-and depressive-like behaviours and alters glutamatergic markers in the prefrontal cortex and hippocampus of male adolescent …
SJ Millard, JS Lum, F Fernandez, K Weston-Green, KA Newell
Journal of Psychopharmacology 33 (2), 230-243, 2019
352019
Ubiquitin homeostasis is disrupted in TDP-43 and FUS cell models of ALS
NE Farrawell, L McAlary, JS Lum, CG Chisholm, ST Warraich, IP Blair, ...
Iscience 23 (11), 2020
322020
Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia
N Matosin, F Fernandez-Enright, JS Lum, JL Andrews, M Engel, ...
Schizophrenia Research 166 (1-3), 212-218, 2015
292015
Neurodevelopmental expression profile of dimeric and monomeric group 1 mGluRs: relevance to schizophrenia pathogenesis and treatment
JS Lum, F Fernandez, N Matosin, JL Andrews, XF Huang, L Ooi, ...
Scientific Reports 6 (1), 34391, 2016
262016
Prenatal methadone exposure impairs adolescent cognition and GABAergic neurodevelopment in a novel rat model of maternal methadone treatment
JS Lum, KM Bird, J Wilkie, SJ Millard, S Pallimulla, KA Newell, IM Wright
Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, 110281, 2021
152021
A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia
JS Lum, SJ Millard, XF Huang, L Ooi, KA Newell
Journal of Psychiatry and Neuroscience 43 (2), 102-110, 2018
132018
Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease. Sci Rep. 2016; 6 …
R Balez, N Steiner, M Engel, SS Muñoz, JS Lum, Y Wu, D Wang, ...
DOI: https://doi. org/10.1038/srep31450. PMID: https://www. ncbi. nlm. nih …, 0
11
Ubiquitin homeostasis disruption, a common cause of proteostasis collapse in amyotrophic lateral sclerosis?
CG Chisholm, JS Lum, NE Farrawell, JJ Yerbury
Neural Regeneration Research, 2022
102022
Identification of repurposable cytoprotective drugs in vanishing white matter disease patient-derived cells
N Ng, MC Cabral-da-Silva, S Maksour, T Berg, M Engel, DM Silva, ...
Translational Medicine Communications 5, 1-10, 2020
92020
CuATSM improves motor function and extends survival but is not tolerated at a high dose in SOD1G93A mice with a C57BL/6 background
JS Lum, ML Brown, NE Farrawell, L McAlary, D Ly, CG Chisholm, J Snow, ...
Scientific Reports 11 (1), 19392, 2021
82021
The system can't perform the operation now. Try again later.
Articles 1–20